5AM Ventures Closes $750 Million Across Two Life Science

SAN FRANCISCO and BOSTON, April 04, 2022 (GLOBE NEWSWIRE) -- 5AM Venture Management, LLC (“5AM”) is pleased to announce the closing of two new funds,...

Related Keywords

Boston ,Massachusetts ,United States ,San Francisco ,California ,America ,Rebecca Lucia ,Andrew Schwab ,Kush Parmar ,Sanofi Genzyme ,Paula Soteropoulos ,Transcelerate Biopharma ,Head Of Specialty Development At Bristol Myers Squibb ,Venture Management ,Tufts Department Of Chemical ,Global Development At Amgen ,Kyowa Kirin Inc ,Managing Partner ,Elliott Levy ,Venture Partner ,Strategic Advisor ,Senior Vice President ,Global Development ,Specialty Development ,Omega Therapeutics ,Akcea Therapeutics ,General Manager ,Rare Diseases ,Strategic Alliances ,Moderna Therapeutics ,Kyowa Kirin ,Cheisi Rare Disease ,Tufts Department ,5am Venture Management ,Lc ,